Senior Reporter
Abbott Laboratories Inc., Arriva Medical LLC, and Alere Inc. secured dismissal of a whistleblower’s False Claims Act suit alleging that the companies improperly billed Medicare for diabetic supplies, a federal district court said.
Troy Olhausen, who filed this suit in 2019, failed to satisfy the materiality element needed to raise a valid FCA claim, Judge Robert N. Scola Jr., of the US District Court for the Southern District of Florida said, granting the defendants’ motion to dismiss with prejudice.
This opinion comes weeks after Scola dismissed a similar suit Olhausen filed in 2021. The 2019 suit required dismissing Olhausen’s ...
AI-powered legal analytics, workflow tools and premium legal & business news.
A US Court of Appeals for the Third Circuit panel heard oral argument on March 18, 2026 in an appeal of a 2025 District of New Jersey decision upholding a jury verdict in favor of qui tam relators,...